XML 45 R26.htm IDEA: XBRL DOCUMENT
v3.21.1

Concentrations | 12 Months Ended
--- | ---
Dec. 31, 2020
Risks and Uncertainties [Abstract] |
CONCENTRATIONS |
| 20. | CONCENTRATIONS
Major Customers For the year ended December 31, 2020, two customers accounted for approximately 84% and 7%, respectively, of the Company’s revenues. For the year ended December 31, 2019, two customers accounted for approximately 21% and 15%, respectively, of the Company’s revenues. For the year ended December 31, 2018, two customers accounted for approximately 16% and 13%, respectively, of the Company’s revenues. Major Suppliers For the year ended December 31, 2020 and 2019, one supplier accounted for 100% of the Company’s purchases. For the year ended December 31, 2018, two suppliers accounted for approximately 31% and 17%, respectively, of the Company’s purchases. Disaggregation of Revenue from Contracts with Customers The following represents the revenues by products, all derived from China:
|  | For the years ended December 31, |
|  | 2020 |  |  | 2019 |  |  | 2018 |
Sale of medical equipment |  |  |  |  |  |  |  |  |
Abdominal CPR Compression |  | $ | 301,549 |  |  | $ | 58,750 |  |  | $ | 221,414 |
Mobile Medicine (sleep apnea diagnostic products) |  |  | 21,776 |  |  |  | 153,644 |  |  |  | 120,930 |
OSAS service (analysis and detection) |  |  | 35,211 |  |  |  | 171,064 |  |  |  | 217,042 |
Total Revenues |  | $ | 358,536 |  |  | $ | 383,458 |  |  | $ | 559,386 |

X
- Definition The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -URI http://asc.fasb.org/topic&trid=2134479 + Details
Name: | us-gaap_ConcentrationRiskDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RisksAndUncertaintiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration